Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis

European Journal of Immunology

Volumn 29, Issue 7, 1999, Pages 2205-2212

  Butler, Debra M ^a   Malfait, Anne Marie ^a   Maini, Ravinder N ^a   Brennan, Fionula M ^a   Feldmann, Marc ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cytokine; In vivo animal model; Inflammation

Indexed keywords

COLLAGEN TYPE 2; CYTOKINE ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HISTOLOGY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNOVIOCYTE;

ANIMALS; ANTIBODIES; ARTHRITIS; COLLAGEN; DOWN-REGULATION; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-12; JOINTS; LYMPH NODES; MALE; MICE; MICE, INBRED DBA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033041866     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199907)29:07<2205::AID-IMMU2205>3.0.CO;2-Z     Document Type: Article

References (36)

1. Feldmann, M., Brennan, F. M. and Maini, R. N., Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996. 14: 397-440.
2. Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M. and Palladino, M. A., Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 1992. 89: 7375-7379.
3. Williams, R. O., Feldmann, M. and Maini, R. N. , Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 1992. 89: 9784-9788.
4. Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J. and Woody, J., Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNFα. Arthritis Rheum. 1993. 36:1681-1690.
5. Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, H. and Woody, J. N., Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a versus placebo in rheumatoid arthritis. Lancet 1994. 344: 1105-1110.
6. Rankin, E. C., Choy, E. H., Kassimos, D., Kingsley, G. H., Sopwith, A. M., Isenberg, D. A. and Panayi, G. S., The therapeutic effects of an engineered human anti-tumour necrosis factor antibody (CDP571) in rheumatoid arthritis. Br. J. Rheumatol. 1995. 34: 334-342.
7. Moreland, L. W., Baumgartner, S. W., Schift, M. H., Tindall, E. A., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., Widmer, M. B. and Blosch, C. M., Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 1997. 337: 195-197.
8. Feldmann, M., Elliot, M. J., Woody, J. N. and Maini, R. N., Anti-TNFα therapy of rheumatoid arthritis. Adv. Immunol. 1997. 64: 243-350.
9. van der Lubbe, P. A., Dijkmans, B. A., Markusse, H. M., Nassander, U. and Breedveld, F. C., A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum. 1995. 38: 1097-1106.
10. Moreland, L. W., Pratt, P. W., Mayes, M. D., Postlethwait, A., Weisman, M. H., Schnitzer, T., Lightfoot, R., Calabrese, L., Zelinger, D. J. and Koopman, W. J., Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis Rheum. 1995. 38: 1581-1588.
11. ® non-depleting, anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis. Arthritis Rheum. 1996. 39: S122.
12. Trembleau, S., Germann, T., Gately, M. K. and Adorini, L, The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 1995. 16: 383-386.
13. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Rocken, M., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994. 180: 1961-1966.
14. Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N. and Feldmann, M., Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 1996. 39: 495-503.
15. Joosten, L. A., Lubberts, E., Durez, P., Helsen, M. M., Jacobs, M. J., Goldman, M. and van den Berg, W. B., Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effects of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 1997. 40: 249-260.
16. Horsfall, A. C., Butler, D. M., Marinova, L., Warden, P. J., Williams, R. O., Maini, R. N. and Feldmann, M., Suppression of collagen-induced arthritis by continuous administration of interleukin-4. J. Immunol. 1997. 159: 5687-5696.
17. Williams, R. O., Williams, D. G., Feldmann, M. and Maini, R. N., Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin. Exp. Immunol. 1993. 92: 323-327.
18. Boissier, M.-C., Chiocchia, G., Bessis, N., Hajnal, J., Garotta, G., Nicoletti, F. and Fournier, C., Biphasic effect of interferon-γ in murine collagen-induced arthritis. Eur. J. Immunol. 1995. 25:1184-1190.
19. Joosten, L. A., Lubberts, E., Helsen, M. M. A. and van den Berg, W. B., Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J. Immunol. 1997.159: 4094-4102.
20. Malfait, A. M., Butler, D. M., Presky, D. H., Maini, R. N., Brennan, F. M. and Feldmann, M., Blockade of interleukin 12 during the induction of collagen-induced arthritis markedly attenuates the severity of the arthritis. Clin. Exp. Immunol. 1998. 111: 377-383.
21. Trinchieri, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995. 13: 251-276.
22. McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Warrier, R. R., Connaughton, S. E., Hall, L. B., Arp. L. H., Gately, M. K. and Magram, J., Reduced incidence and severity of collagen-induced arthritis in interleukin-12 deficient mice. Eur. J. Immunol. 1996. 26: 2933-2938.
23. Williams, R. O., Ghrayeb, J., Feldmann, M. and Maini, R. N., Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 1995. 84: 433-439.
24. Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R. R. F., Ferenx, C., Herwick, R. M., Kelleher, K., Herrmann, S. H., Clark, S. C., Anzzoni, L., Chan, S. H., Trinchieri, G. and Perussia, B., Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Immunol. 1991. 146: 3074-3081.
25. Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospisil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C. and Trinchieri, G., Induction of Interferon γ production by natural killer stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 1991. 173: 869-879.
26. Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J. F., Beckmann, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mosmann, T. R. and Paul, W. E., Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 1990. 8: 303-334.
27. Hart, P. H., Whitty, G. A., Piccoli, D. S. and Hamilton, J. A., Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-γ. Increased TNFα but not IL-1 activity. J. Exp. Med. 1988. 141: 1516-1521.
28. Flesch, I. E., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H. and Kaufmann, S. H., Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 1995. 181: 1615-1621.
29. Liu, Z. G., Hsu, H., Goeddel, D. V. and Karin, M., Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-(greek small letter script kappa)B activation prevents cell death. Cell 1996. 87: 565-676.
30. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M., Suppression of TNF-α-induced apoptosis by NF-(greek small letter script kappa)B. Science 1996. 274: 787-789.
31. Williams, R. O., Mason, L. J., Feldmann, M. and Maini, R. N., Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 1994. 91: 2762-2766.
32. Wysocka, M., Kubin, M., Veira, L. Q., Ozmen, L., Garotta, G., Scott, P. and Trinchieri, G., Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 1995. 25: 672-676.
33. Mauri, C., Williams, R. O., Walmsley, M. and Feldmann, M., Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 1996. 26: 1511-1514.
34. Butler, D. M., Malfait, A. M., Mason, L. J., Warden, P. J., Kollias, G., Maini, R. N., Feldmann, M. and Brennan, F. M., DBA/1 mice expressing the human TNFa transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J. Immunol. 1997. 159: 2867-2876.
35. Espevik, T. and Nissen-Meyer, J., A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 1986. 95: 99-105.
36. Baker, D., Butler, D., Scallon, B. J., O'Neill, J. K., Turk, J. L. and Feldmann, M., Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 1994. 24: 2040-2048.